# EDGAR Filing Document

**Accession Number:** 0001569064
**File Stem:** 0001172661-25-003987
**Filing Date:** 2025-8
**Character Count:** 59486
**Document Hash:** 02e93fae69c624168b0f2072ee8e4e1f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001172661-25-003987.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001172661-25-003987

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SUVRETTA CAPITAL MANAGEMENT, LLC
- **CENTRAL INDEX KEY:** 0001569064

**ORGANIZATION NAME:**
- **EIN:** 453704500
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-15929
- **FILM NUMBER:** 251277723

**BUSINESS ADDRESS:**
- **STREET 1:** 540 MADISON AVENUE
- **STREET 2:** 7TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 2127025204

**MAIL ADDRESS:**
- **STREET 1:** 540 MADISON AVENUE
- **STREET 2:** 7TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001569064

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** SUVRETTA CAPITAL MANAGEMENT, LLC

**Address:** 540 MADISON AVENUE, NEW YORK, NY 10022

**Telephone number:** 212-702-5204

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-15929

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                     | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                  | VOTE CATEGORY                |     SHARES VOTED |   SHARES ON LOAN | HOW VOTED   | SHARES VOTED FOR OR AGAINST MANAGEMENT   | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|:---|:---|:---|
| 89bio, Inc.                        | 282559103 | 05/28/2025     | Approval of, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |      1.44364e+07 |                0 | FOR         | 14436376.000000                          | FOR                         |  |
| Abeona Therapeutics Inc.           | 00289Y206 | 05/19/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |      3.27817e+06 |                0 | FOR         | 3278166.000000                           | FOR                         |  |
| Advanced Micro Devices, Inc.       | 007903107 | 05/14/2025     | Approve on a non-binding, advisory basis the compensation of the named executive officers, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |  14433           |                0 | FOR         | 14433.000000                             | FOR                         |  |
| Agilent Technologies, Inc.         | 00846U101 | 03/13/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |   4222           |                0 | FOR         | 4222.000000                              | FOR                         |  |
| Align Technology, Inc.             | 016255101 | 05/21/2025     | Advisory Vote to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |    973           |                0 | FOR         | 973.000000                               | FOR                         |  |
| Alnylam Pharmaceuticals, Inc.      | 02043Q107 | 05/08/2025     | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |   9370           |                0 | FOR         | 9370.000000                              | FOR                         |  |
| Amazon.com, Inc.                   | 023135106 | 05/21/2025     | ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 354356           |                0 | AGAINST     | 354356.000000                            | AGAINST                     |  |
| Apellis Pharmaceuticals, Inc.      | 03753U106 | 06/03/2025     | To hold an advisory vote to approve the compensation paid to our named executive officers;                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |      1.83513e+06 |                0 | AGAINST     | 1835131.000000                           | AGAINST                     |  |
| Apellis Pharmaceuticals, Inc.      | 03753U106 | 06/03/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers; and                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |      1.83513e+06 |                0 | ONE YEAR    | 1835131.000000                           | FOR                         |  |
| Arcus Biosciences, Inc.            | 03969F109 | 06/10/2025     | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |      3.3985e+06  |                0 | FOR         | 3398503.000000                           | FOR                         |  |
| Arcutis Biotherapeutics, Inc.      | 03969K108 | 06/12/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |      1.05849e+07 |                0 | FOR         | 10584866.000000                          | FOR                         |  |
| Avantor, Inc.                      | 05352A100 | 05/08/2025     | Approve, on an Advisory Basis, Named Executive Officer Compensation.                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |  12624           |                0 | FOR         | 12624.000000                             | FOR                         |  |
| Bank of America Corporation        | 060505104 | 04/22/2025     | Approving our executive compensation (an advisory, non-binding "Say on Pay" resolution)                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 433952           |                0 | AGAINST     | 433952.000000                            | AGAINST                     |  |
| Baxter International Inc.          | 071813109 | 05/06/2025     | Advisory Vote to Approve Named Executive Officer Compensation for 2024                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |    942           |                0 | FOR         | 942.000000                               | FOR                         |  |
| Beam Therapeutics Inc.             | 07373V105 | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| Becton, Dickinson and Company      | 075887109 | 01/28/2025     | Advisory vote to approve named executive officer compensation.                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |    560           |                0 | FOR         | 560.000000                               | FOR                         |  |
| Benitec Biopharma Inc.             | 08205P209 | 12/04/2024     | Approval of the non-binding advisory vote on the compensation of the Company's named executive officers as disclosed in the attached proxy statement.                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |      8.82301e+06 |                0 | FOR         | 8823009.000000                           | FOR                         |  |
| Biogen Inc.                        | 09062X103 | 06/17/2025     | Say on Pay - To hold an advisory vote on executive compensation.                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 131490           |                0 | AGAINST     | 131490.000000                            | AGAINST                     |  |
| Biohaven Ltd.                      | G1110E107 | 05/05/2025     | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |      5.27445e+06 |                0 | FOR         | 5274452.000000                           | FOR                         |  |
| Bio-Techne Corporation             | 09073M104 | 10/24/2024     | Approve, on an advisory basis, the compensation of our executive officers.                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |   2600           |                0 | FOR         | 2600.000000                              | FOR                         |  |
| Boston Scientific Corporation      | 101137107 | 05/01/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 421859           |                0 | FOR         | 421859.000000                            | FOR                         |  |
| Bruker Corporation                 | 116794108 | 05/29/2025     | Approval on an advisory basis of the 2024 compensation of our named executive officers, as discussed in the Proxy Statement.                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |     45           |                0 | FOR         | 45.000000                                | FOR                         |  |
| Caesars Entertainment, Inc.        | 12769G100 | 06/10/2025     | COMPANY PROPOSAL: ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| Capital One Financial Corporation  | 14040H105 | 05/08/2025     | Advisory vote on our Named Executive Officer compensation ("Say on Pay").                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES | 186520           |                0 | FOR         | 186520.000000                            | FOR                         |  |
| Cencora, Inc.                      | 03073E105 | 03/06/2025     | Advisory vote to approve the fiscal 2024 compensation of Cencora, Inc.'s named executive officers.                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |   5053           |                0 | FOR         | 5053.000000                              | FOR                         |  |
| Chipotle Mexican Grill, Inc.       | 169656105 | 06/11/2025     | An advisory vote to approve the compensation of our executive officers as disclosed in the proxy statement ("say-on-pay").                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| CRH Plc                            | G25508105 | 05/08/2025     | Consideration of Named Executive Officer Compensation for 2024 ("Say-on-Pay")                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |  14050           |                0 | FOR         | 14050.000000                             | FOR                         |  |
| CRH Plc                            | G25508105 | 05/08/2025     | Consideration of Frequency of Future "Say-on-Pay" Votes                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |  14050           |                0 | ONE YEAR    | 14050.000000                             | FOR                         |  |
| Danaher Corporation                | 235851102 | 05/06/2025     | To approve on an advisory basis the Company's named executive officer compensation.                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |  13600           |                0 | FOR         | 13600.000000                             | FOR                         |  |
| Datadog, Inc.                      | 23804L103 | 06/03/2025     | Advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES | 102841           |                0 | FOR         | 102841.000000                            | FOR                         |  |
| DBV Technologies SA                | F2927N109 | 06/11/2025     | Approval of the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2024, to Mr. Michel de Rosen, Chairman of the Board of Directors                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |      0           |           210221 |  |  |  |  |
| DBV Technologies SA                | F2927N109 | 06/11/2025     | Approval of the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2024, to Mr. Daniel Tasse, Chief Executive Officer                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |      0           |           210221 |  |  |  |  |
| DBV Technologies SA                | F2927N109 | 06/11/2025     | Advisory opinion on the compensation of named executive officers other than the Chief Executive Officer                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |      0           |           210221 |  |  |  |  |
| DexCom, Inc.                       | 252131107 | 05/08/2025     | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024.                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |   5839           |                0 | FOR         | 5839.000000                              | FOR                         |  |
| Edwards Lifesciences Corporation   | 28176E108 | 05/08/2025     | Advisory Vote to Approve Named Executive Officer Compensation                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |   1778           |                0 | FOR         | 1778.000000                              | FOR                         |  |
| Elanco Animal Health Incorporated  | 28414H103 | 05/16/2025     | Advisory vote on the compensation of the company's named executive officers.                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |     84           |                0 | FOR         | 84.000000                                | FOR                         |  |
| Elanco Animal Health Incorporated  | 28414H103 | 05/16/2025     | Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executive officers.                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |     84           |                0 | ONE YEAR    | 84.000000                                | FOR                         |  |
| Elevance Health, Inc.              | 036752103 | 05/14/2025     | Advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |   2740           |                0 | FOR         | 2740.000000                              | FOR                         |  |
| Exact Sciences Corporation         | 30063P105 | 06/12/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |    117           |                0 | FOR         | 117.000000                               | FOR                         |  |
| EyePoint Pharmaceuticals, Inc.     | 30233G209 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement.                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |      5.94632e+06 |                0 | FOR         | 5946322.000000                           | FOR                         |  |
| EyePoint Pharmaceuticals, Inc.     | 30233G209 | 06/18/2025     | To vote, on an advisory basis, on the frequency of advisory stockholder votes on the compensation paid to our named executive officers.                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |      5.94632e+06 |                0 | ONE YEAR    | 5946322.000000                           | FOR                         |  |
| Ferguson Enterprises Inc.          | 31488V107 | 12/05/2024     | To approve, on an advisory basis, the fiscal 2024 compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES | 225210           |                0 | FOR         | 225210.000000                            | FOR                         |  |
| Ferguson Enterprises Inc.          | 31488V107 | 12/05/2024     | To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES | 225210           |                0 | ONE YEAR    | 225210.000000                            | FOR                         |  |
| Fortrea Holdings Inc.              | 34965K107 | 06/10/2025     | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers.                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |    110           |                0 | FOR         | 110.000000                               | FOR                         |  |
| Fulcrum Therapeutics, Inc.         | 359616109 | 06/26/2025     | A non-binding advisory vote on executive compensation;                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |      5.22388e+06 |                0 | FOR         | 5223879.000000                           | FOR                         |  |
| Fulcrum Therapeutics, Inc.         | 359616109 | 06/26/2025     | A non-binding advisory vote on the frequency of future executive compensation advisory votes; and                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      5.22388e+06 |                0 | ONE YEAR    | 5223879.000000                           | FOR                         |  |
| GE Aerospace                       | 369604301 | 05/06/2025     | Advisory Approval of Our Named Executives' Compensation                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 200662           |                0 | AGAINST     | 200662.000000                            | AGAINST                     |  |
| HCA Healthcare, Inc.               | 40412C101 | 04/24/2025     | Advisory vote to approve named executive officer compensation.                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |      1           |                0 | FOR         | 1.000000                                 | FOR                         |  |
| Insmed Incorporated                | 457669307 | 05/15/2025     | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |      1.4602e+06  |                0 | FOR         | 1460199.000000                           | FOR                         |  |
| Intra-Cellular Therapies, Inc.     | 46116X101 | 03/27/2025     | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to ITI's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement.                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 700904           |                0 | FOR         | 700904.000000                            | FOR                         |  |
| Intuitive Surgical, Inc.           | 46120E602 | 05/01/2025     | To approve, by advisory vote, the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |   2567           |                0 | FOR         | 2567.000000                              | FOR                         |  |
| Ionis Pharmaceuticals, Inc.        | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation.                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |  10800           |                0 | FOR         | 10800.000000                             | FOR                         |  |
| IQVIA Holdings Inc.                | 46266C105 | 04/24/2025     | Approve an advisory (non-binding) resolution to approve IQVIA'S executive compensation (say-on-pay).                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |   7031           |                0 | FOR         | 7031.000000                              | FOR                         |  |
| Johnson  Johnson                   | 478160104 | 04/24/2025     | Advisory Vote to Approve Named Executive Officer Compensation                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES | 109386           |                0 | FOR         | 109386.000000                            | FOR                         |  |
| KalVista Pharmaceuticals, Inc.     | 483497103 | 10/03/2024     | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |      3.60924e+06 |                0 | FOR         | 3609237.000000                           | FOR                         |  |
| Kezar Life Sciences, Inc.          | 49372L209 | 06/17/2025     | Advisory vote on the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 716759           |                0 | AGAINST     | 716759.000000                            | AGAINST                     |  |
| Kura Oncology, Inc.                | 50127T109 | 06/05/2025     | Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |      7.45239e+06 |                0 | FOR         | 7452388.000000                           | FOR                         |  |
| McKesson Corporation               | 58155Q103 | 07/31/2024     | Advisory vote on Executive Compensation                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |  56279           |                0 | FOR         | 56279.000000                             | FOR                         |  |
| Medpace Holdings, Inc.             | 58506Q109 | 05/16/2025     | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |      5           |                0 | FOR         | 5.000000                                 | FOR                         |  |
| Medtronic Plc                      | G5960L103 | 10/17/2024     | Approving, on an advisory basis, the Company's executive compensation;                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |  17460           |                0 | FOR         | 17460.000000                             | FOR                         |  |
| Merck  Co., Inc.                   | 58933Y105 | 05/27/2025     | Non-binding advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES | 144100           |                0 | FOR         | 144100.000000                            | FOR                         |  |
| Meta Platforms, Inc.               | 30303M102 | 05/28/2025     | To approve, on a non-binding advisory basis, the compensation program for Meta Platforms, Inc.'s named executive officers as disclosed in Meta Platforms, Inc.'s proxy statement.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 179664           |                0 | AGAINST     | 179664.000000                            | AGAINST                     |  |
| Meta Platforms, Inc.               | 30303M102 | 05/28/2025     | To vote, on a non-binding advisory basis, whether a non-binding advisory vote on the compensation program for Meta Platforms, Inc.'s named executive officers should be held every one, two or three years.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES | 179664           |                0 | ONE YEAR    | 179664.000000                            | AGAINST                     |  |
| Mettler-Toledo International Inc.  | 592688105 | 05/01/2025     | ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |   1964           |                0 | FOR         | 1964.000000                              | FOR                         |  |
| Microsoft Corporation              | 594918104 | 12/10/2024     | Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote")                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |  18269           |                0 | FOR         | 18269.000000                             | FOR                         |  |
| Moderna, Inc.                      | 60770K107 | 04/30/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 517163           |                0 | AGAINST     | 517163.000000                            | AGAINST                     |  |
| Natera, Inc.                       | 632307104 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |  10100           |                0 | FOR         | 10100.000000                             | FOR                         |  |
| NVIDIA Corporation                 | 67066G104 | 06/25/2025     | Advisory approval of our executive compensation.                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 298462           |                0 | FOR         | 298462.000000                            | FOR                         |  |
| Oracle Corporation                 | 68389X105 | 11/14/2024     | Advisory Vote to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |  57757           |                0 | AGAINST     | 57757.000000                             | AGAINST                     |  |
| Palvella Therapeutics, Inc.        | 697947109 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 714463           |                0 | FOR         | 714463.000000                            | FOR                         |  |
| Quest Diagnostics Incorporated     | 74834L100 | 05/15/2025     | An advisory resolution to approve the executive officer compensation disclosed in the Company's 2025 proxy statement                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |     95           |                0 | FOR         | 95.000000                                | FOR                         |  |
| Repligen Corporation               | 759916109 | 05/15/2025     | Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers.                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |    830           |                0 | FOR         | 830.000000                               | FOR                         |  |
| ResMed Inc.                        | 761152107 | 11/20/2024     | Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay").                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |   2390           |                0 | FOR         | 2390.000000                              | FOR                         |  |
| Revvity, Inc.                      | 714046109 | 04/22/2025     | To approve, by non-binding advisory vote, our executive compensation.                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |    165           |                0 | FOR         | 165.000000                               | FOR                         |  |
| Roblox Corporation                 | 771049103 | 05/29/2025     | Advisory Vote on the Compensation of our Named Executive Officers.                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| Rocket Pharmaceuticals, Inc.       | 77313F106 | 06/18/2025     | Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers;                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |      4.09439e+06 |                0 | FOR         | 4094387.000000                           | FOR                         |  |
| Sanofi                             | 80105N105 | 04/30/2025     | Approve Compensation of Frederic Oudea, Chairman of the Board                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |  79024           |                0 | FOR         | 79024.000000                             | FOR                         |  |
| Sanofi                             | 80105N105 | 04/30/2025     | Approve Compensation of Paul Hudson, CEO                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |  79024           |                0 | FOR         | 79024.000000                             | FOR                         |  |
| Sarepta Therapeutics, Inc.         | 803607100 | 06/05/2025     | ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATION                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |  17888           |                0 | FOR         | 17888.000000                             | FOR                         |  |
| Starbucks Corporation              | 855244109 | 03/12/2025     | Approve, on an advisory, nonbinding basis, the compensation of our named executive officers                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| STERIS plc                         | G8473T100 | 08/01/2024     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2024. | SECTION 14A SAY-ON-PAY VOTES |    153           |                0 | FOR         | 153.000000                               | FOR                         |  |
| Stryker Corporation                | 863667101 | 05/08/2025     | Advisory Vote to Approve Named Executive Officer Compensation.                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |   5370           |                0 | FOR         | 5370.000000                              | FOR                         |  |
| Sutro Biopharma, Inc.              | 869367102 | 06/06/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |      7.42474e+06 |                0 | AGAINST     | 7424745.000000                           | AGAINST                     |  |
| The Coca-Cola Company              | 191216100 | 04/30/2025     | Advisory vote to approve executive compensation                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |  64988           |                0 | FOR         | 64988.000000                             | FOR                         |  |
| The Goldman Sachs Group, Inc.      | 38141G104 | 04/23/2025     | Advisory Vote to Approve Executive Compensation (Say on Pay)                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |  25538           |                0 | AGAINST     | 25538.000000                             | AGAINST                     |  |
| The Home Depot, Inc.               | 437076102 | 05/22/2025     | Advisory Vote to Approve Executive Compensation ("Say-on-Pay")                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |  58176           |                0 | FOR         | 58176.000000                             | FOR                         |  |
| The Walt Disney Company            | 254687106 | 03/20/2025     | Consideration of an advisory vote to approve executive compensation.                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| Thermo Fisher Scientific Inc.      | 883556102 | 05/21/2025     | An advisory vote to approve named executive officer compensation.                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| Trevi Therapeutics, Inc.           | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| Trevi Therapeutics, Inc.           | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to our named executive officers.                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| Ultragenyx Pharmaceutical Inc.     | 90400D108 | 05/15/2025     | Advisory (non-binding) vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |      2.00194e+06 |                0 | AGAINST     | 2001935.000000                           | AGAINST                     |  |
| United Airlines Holdings, Inc.     | 910047109 | 05/21/2025     | A vote to approve, on a nonbinding advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |      0           |                0 |  |  |  |  |
| UnitedHealth Group Incorporated    | 91324P102 | 06/02/2025     | Advisory approval of the Company's executive compensation.                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |  29900           |                0 | AGAINST     | 29900.000000                             | AGAINST                     |  |
| Unity Software Inc.                | 91332U101 | 06/11/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement.                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 306748           |                0 | AGAINST     | 306748.000000                            | AGAINST                     |  |
| Veralto Corp.                      | 92338C103 | 05/14/2025     | To approve on an advisory basis the Company's named executive officer compensation.                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |    407           |                0 | FOR         | 407.000000                               | FOR                         |  |
| Waters Corporation                 | 941848103 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers; and                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |   3150           |                0 | FOR         | 3150.000000                              | FOR                         |  |
| West Pharmaceutical Services, Inc. | 955306105 | 05/06/2025     | Advisory vote to approve named executive officer compensation;                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |    210           |                0 | FOR         | 210.000000                               | FOR                         |  |
| Zimmer Biomet Holdings, Inc.       | 98956P102 | 05/29/2025     | Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay").                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |   3260           |                0 | FOR         | 3260.000000                              | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** SUVRETTA CAPITAL MANAGEMENT, LLC

**By (Signature):** Glenn Shepard

**By (Printed Signature):** Glenn Shepard

**By (Title):** Chief Financial Officer

**Date:** 08/29/2025